Using texting to help manage high blood pressure in older adults
A Pharmacist Intervention for Monitoring and Treating Hypertension Using Bidirectional Texting
This study is looking at how a texting service can help older adults with high blood pressure by letting them send their home readings to pharmacists, who can then offer quick support and adjust treatments to keep their blood pressure in check, especially for those living in rural areas.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Iowa NIH-funded |
| Lab location | 1 site (Iowa City, United States) |
| Project ID | NIH-10685296 on NIH RePORTER |
What this research studies
This research investigates a telehealth service that utilizes a bi-directional texting platform to monitor and treat hypertension in older adults. Patients will send their home blood pressure readings via SMS, allowing pharmacists to provide timely interventions and adjust treatments as necessary. The approach aims to improve blood pressure control, particularly in rural and underserved populations, by integrating this service into existing healthcare workflows. The study builds on previous successful collaborations between physicians and pharmacists to enhance patient care.
Who could benefit from this research
Good fit: Ideal candidates for this research are older adults, particularly those living in rural areas or with limited access to healthcare services.
Not a fit: Patients who do not have hypertension or those who are not comfortable using text messaging may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better management of hypertension in older adults, reducing the risk of serious cardiovascular events.
How similar studies have performed: Previous studies have shown success in using telehealth and pharmacist interventions to manage hypertension, indicating a promising approach.
Where this research is happening
Iowa City, United States
- University of Iowa — Iowa City, United States (Active)
Researchers
- Principal investigator: Polgreen, Linnea Ann — University of Iowa
- Study coordinator: Polgreen, Linnea Ann
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.